These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9543218)

  • 1. Characteristics of chronic venous insufficiency in 895 patients followed in general practice.
    Boccalon H; Janbon C; Saumet JL; Tafani A; Roux T; Vilain C
    Int Angiol; 1997 Dec; 16(4):226-34. PubMed ID: 9543218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of mesoglycan in patients with previous deep venous thrombosis and chronic venous insufficiency.
    Andreozzi GM
    Minerva Cardioangiol; 2007 Dec; 55(6):741-53. PubMed ID: 18091643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of a venotropic drug in man. Example of Daflon 500 mg.
    Laurent R; Gilly R; Frileux C
    Int Angiol; 1988; 7(2 Suppl):39-43. PubMed ID: 3053942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demographic factors and their relationship with the presence of CVI signs in Italy: the 24-cities cohort study.
    Chiesa R; Marone EM; Limoni C; Volonté M; Schaefer E; Petrini O
    Eur J Vasc Endovasc Surg; 2005 Dec; 30(6):674-80. PubMed ID: 16055355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced chronic venous insufficiency is associated with increased calf muscle deoxygenation.
    Yamaki T; Nozaki M; Sakurai H; Soejima K; Kono T; Hamahata A
    Eur J Vasc Endovasc Surg; 2010 Jun; 39(6):787-94. PubMed ID: 20227896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk factors of chronic venous insufficiency of the lower extremities and possibilities of its medication in therapeutic practice].
    Oganov RG; Savel'ev VS; Shal'nova SA; Kirienko AI; Zolotukhin IA
    Ter Arkh; 2006; 78(4):68-72. PubMed ID: 16821427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Derivatives of semi-synthetic diosmine in the treatment of patients with chronic venous insufficiency. The results of a prospective study--using phlebodia 600].
    Pokrovskiĭ AV; Sapelkin SV
    Angiol Sosud Khir; 2005; 11(4):73-9. PubMed ID: 16474293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Semisynthetic Diosmin (Phlebodia 600) for therapy of lower limb chronic venous insufficiency].
    Kirienko AI; Bogachev VIu; Zolotukhin IA; Golovanova OV
    Angiol Sosud Khir; 2006; 12(2):73-5. PubMed ID: 17053765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic venous insufficiency: worldwide results of the RELIEF study. Reflux assEssment and quaLity of lIfe improvEment with micronized Flavonoids.
    Jantet G
    Angiology; 2002; 53(3):245-56. PubMed ID: 12025911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Microcirculation end effect of detralex in patients with chronic venous insufficiency of the lower extremities].
    Sirotin BZ; Zhmerenetskĭ KV
    Angiol Sosud Khir; 2003; 9(3):60-5. PubMed ID: 14657934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A double-blind study comparing the clinical efficacy of the preparation F-117 (hidrosmin) versus diosmin in the treatment of patients with peripheral venous disorders].
    Honorato Pérez J; Arcas Meca R
    Rev Med Univ Navarra; 1990; 34(2):77-9. PubMed ID: 2130425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of clinical efficacy of a venotonic drug: lessons of a therapeutic trial with hemisynthesis diosmin in "heavy legs syndrome"].
    Carpentier PH; Mathieu M
    J Mal Vasc; 1998 Apr; 23(2):106-12. PubMed ID: 9608923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double blind study of the pharmacodynamic and clinical activities of 5682 SE in venous insufficiency. Advantages of the new micronized form.
    Cospite M; Dominici A
    Int Angiol; 1989; 8(4 Suppl):61-5. PubMed ID: 2698903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of venous insufficiency in an occupational population.
    Lacroix P; Aboyans V; Preux PM; Houlès MB; Laskar M
    Int Angiol; 2003 Jun; 22(2):172-6. PubMed ID: 12865883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic venous insufficiency--outpatient study of risk factors].
    Musil D; Herman J
    Vnitr Lek; 2004 Jan; 50(1):14-20. PubMed ID: 15015225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of administering Phlebodia 600 in fertile women with orthostasis-dependent phlebopathy].
    Tsukanov IuT; Tsukanov AIu
    Angiol Sosud Khir; 2007; 13(3):107-12. PubMed ID: 18382403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Edema as a measure for severity of chronic venous insufficiency and efficacy of its treatment].
    Sapelkin SV
    Angiol Sosud Khir; 2008; 14(3):79-81. PubMed ID: 19791434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired ambulatory venous function in lymphedema assessed by near-infrared spectroscopy.
    Saito T; Hosoi Y; Onozuka A; Komiyama T; Miyata T; Shigematsu H; Nagawa H
    Int Angiol; 2005 Dec; 24(4):336-9. PubMed ID: 16355090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pelvic venous incompetence: reflux patterns and treatment results.
    Asciutto G; Asciutto KC; Mumme A; Geier B
    Eur J Vasc Endovasc Surg; 2009 Sep; 38(3):381-6. PubMed ID: 19574069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of clinical trials of Cyclo 3 Fort in the treatment of chronic venous insufficiency.
    Boyle P; Diehm C; Robertson C
    Int Angiol; 2003 Sep; 22(3):250-62. PubMed ID: 14612852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.